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Abstract
For patients with acute respiratory insufficiency, mechanical 
(“invasive”) ventilation is a fundamental therapeutic mea-
sure to ensure sufficient gas exchange. Despite decades of 
strong research efforts, central questions on mechanical 
ventilation therapy are still answered incompletely. There-
fore, many different ventilation modes and settings have 
been used in daily clinical practice without scientifically 
sound bases. At the same time, implementation of the few 
evidence-based therapeutic concepts (e.g., “lung protective 
ventilation”) into clinical practice is still insufficient. The aim 
of our guideline project “Mechanical ventilation and extra-
corporeal gas exchange in acute respiratory insufficiency” 
was to develop an evidence-based decision aid for treating 
patients with and on mechanical ventilation. It covers the 
whole pathway of invasively ventilated patients (including 
indications of mechanical ventilation, ventilator settings, ad-
ditional and rescue therapies, and liberation from mechani-
cal ventilation). To assess the quality of scientific evidence 
and subsequently derive recommendations, we applied the 
Grading of Recommendations, Assessment, Development 
and Evaluation method. For the first time, using this globally 
accepted methodological standard, our guideline contains 
recommendations on mechanical ventilation therapy not 
only for acute respiratory distress syndrome patients but 
also for all types of acute respiratory insufficiency. This re-
view presents the two main chapters of the guideline on 
choosing the mode of mechanical ventilation and setting its 
parameters. The guideline group aimed that – by thorough 
implementation of the recommendations – critical care 
teams may further improve the quality of care for patients 
suffering from acute respiratory insufficiency. By identifying 
relevant gaps of scientific evidence, the guideline group in-
tended to support the development of important research 
projects. © 2019 S. Karger AG, Basel
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Introduction and Methodology
Mechanical (“invasive”) ventilation via endotracheal 
tube or tracheal cannula is an essential therapy for pa-
tients with acute respiratory insufficiency.
Despite a large number of studies on mechanical ven-
tilation, there has been a lack of a comprehensive clinical 
treatment guideline based on systematic literature re-
search and evaluation. In 2017, one international ATS/
ERS practice guideline as well as one multi-disciplinary 
guideline from 21 scientific societies from Germany, Swit-
zerland, and Austria – both on mechanical ventilation – 
were published [1, 2]. Both guidelines were developed ac-
cording to the internationally accepted Grading of Rec-
ommendations, Assessment, Development and Evaluation 
(GRADE) method based on systematic literature search 
and assessment [3]. While the ATS/ERS statement fo-
cused on 6 specific therapeutic questions (tidal volume, 
PEEP-level, prone positioning, high-frequency oscillation 
ventilation (HFOV), recruitment maneuvers, and vvEC-
MO) regarding only patients with acute respiratory dis-
tress syndrome (ARDS), the multidisciplinary evidence- 
and consensus-based (= S3) guideline from the German-
speaking countries developed a comprehensive clinical 
practice guideline reflecting the entire therapeutic path-
way of patients with acute respiratory insufficiency treat-
ed in an intensive care unit.
The current practice of care of mechanically ventilated 
patients is inhomogeneous: some simple, scientifically 
proven, and mortality lowering measures as limiting tid-
al volume and peak inspiratory pressure are clinically ap-
plied in only about two-third of the patients with ARDS 
[4]. At the same time, technically improved extracorpo-
real gas exchange devices are used more frequently and in 
part uncritically without sufficient scientific evidence of 
a beneficial effect for those patients [5].
The aim of this S3 guideline is to provide an evidence-
based source of information and decision support on the 
clinical issues associated with mechanical ventilation and 
extracorporeal gas exchange in patients with acute respi-
ratory insufficiency. The structure of the guideline fol-
lows the typical clinical pathway in an intensive care unit. 
Indications of and, if necessary, alternatives to mechani-
cal ventilation, choice of ventilation modes, setting the 
parameters of mechanical ventilation, adjunctive mea-
sures, procedure for refractory hypoxemia, as well as 
weaning and follow-up care after mechanical ventilation 
are discussed successively.
In this summary, we present the recommendations of 
this guideline on ventilation mode and setting the param-
eters of mechanical ventilation. Their implementation in 
daily clinical practice should generate suitable benefit for 
the critical ill patient or hinder further harm, at least. The 
complete version in German language [6] is available at 
(http://www.awmf.org/leitlinien/detail/ll/001-021.html).
The guideline group was methodically supported by 
representatives of the AWMF and consisted of 59 man-
date holders from 21 scientific societies from Germany, 
Austria, and Switzerland including representatives of all 
disciplines and professions of the ICU team as well as pa-
tient representatives (Table 1). During the 4-year devel-
opmental period of the guidelines, the group members 
made statements on possible conflicts of interest, which 
were evaluated. In the event of relevant conflicts of inter-
est, the members abstained from voting on the respective 
recommendations. A detailed description of conflicts of 
interest rules is provided in the guideline report.
Methodologically, the guidelines follow the approach 
of the international GRADE working group [3]. 
Initially, clinically relevant questions were developed 
according to the Patient-Intervention-Control-Outcome 
structure. This was followed by systematic literature re-
search in Medline (via PubMed), Embase, Cochrane, and 
the Guidelines International Network and National 
Guideline Clearing House databases.
The literature was selected according to predefined 
criteria, the selected studies were sorted according to the 
study type, and a full-text database comprising approxi-
mately 3,500 studies was created. 
At first, national and international guidelines were ex-
amined for content and quality. Relevant recommenda-
tions of current, high-quality guidelines were adopted. 
Thereafter, current meta-analyses and systematic reviews 
were analyzed for content and quality; the methodologi-
cal quality was critically appraised by external method-
ologists with statistical expertise on the basis of the crite-
ria of the Scottish Intercollegiate Guidelines Network. In 
the absence of adoptable meta-analyses, the analysis and 
evaluation of RCTs and – only in case of missing high 
quality RCTs – studies of lower evidence quality were car-
ried out and documented in evidence tables. Finally, the 
body of evidence for each question was summarized in an 
evidence profile and evaluated qualitatively according to 
the GRADE criteria (Table 2). Evidence quality was pro-
vided in 5 categories (Table 2).
The guideline recommendations are based on a total 
of 297 evaluated guidelines and studies, details can be 
found in the evidence reports of the guideline [7–9].
For content and strength of recommendation (StoRe), 
the benefits and risks of a specific therapy were evaluated 
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Table 1. The guideline group
Guideline group 
Coordination
Dr. med. Falk Fichtner, DGAI
Prof. Dr. med. Onnen Moerer, DGAI
PD Dr. med. Sven Laudi, DGAI
Prof. Dr. med. Steffen Weber-Carstens, DGAI
Prof. Dr. med. Udo Kaisers, DGAI
Authors
Prof. Dr. Michael Adamzik*, DGAI
PD Dr. Andreas Bauer*, DGAI
Prof. Dr. Thomas Bein*, DGAI
Prof. Dr. Christoph Benk*, DGfK
Dr. Dirk Buchwald*, DGfK
Prof. Dr. Iris Chaberny*, DGHM
Prof. Dr. Maria Deja*, DGAI
Dr. Sandra Delis*, DGPalliativmedizin
Prof. Dr. Rolf Dembinski*, DGAI
Rolf Dubb*, DGF
Prof. Dr. Bjoern Ellger*, DGAI
Dr. Falk Fichtner, DGAI
Prof. Dr. Helmut Frohnhofen*, DGG
Prof. Dr. Marcelo Gama de Abreu*, DGAI
Prof. Dr. Christoph Haberthuer*, SGI
Prof. Dr. Marcus Hennersdorf*, DGK
Prof. Dr. Uwe Janssens*, DGK
Prof. Dr. Udo Kaisers, DGAI
Prof. Dr. Christian Karagiannidis*, DGP
Prof. Dr. Stefan Klotz*, DGTHG
Prof. Dr. Stefan Kluge*, DGIIN
PD Dr. Sven Laudi, DGAI
Prof. Dr. Klaus Markstaller*, ÖGARI
Prof. Dr. Frauke Mattner*, DGHM
Prof. Dr. Onnen Moerer, DGAI
Prof. Dr. Ralf Muellenbach*, DGAI
Dr. Anika Mueller*, DGAI
PD Dr. Thomas Mueller*, DGP
Prof. Dr. Wolfgang Muellges*, DGN und DGNI
Prof. Dr. Peter Neumann*, DGAI
Dr. Jan-Oliver Neumann*, DGNC
Prof. Dr. Thomas Nicolai*, DGKJ und DGNI
Prof. Dr. Christian Putensen*, DGAI
Prof. Dr. Michael Quintel*, DGAI
Prof. Dr. Maximilian Ragaller*, DGAI
Prof. Dr. Rolf Rossaint*, DGAI
Dr. med. Dirk Schaedler*, DGAI
PD Dr. Thomas Schaible*, DGNI und DGKJ
Prof. Dr. Bernd Schoenhofer*, DIVI
Dr. Dierk Schreiter*, DGC
Dr. Christian Seeber*, DGAI
Prof. Dr. Steffen Weber-Carstens, DGAI
Dr. Bjoern Weiss*, DGAI
Prof. Dr. Hermann Wrigge*, DGAI
Further members of the guideline group
Enrico Bock, DGF
Prof. Dr. Udo Boeken*, DGTHG
Uta Brueckner*, ZVK
Ron Fantl*, DGP
Prof. Dr. Marius Hoeper*, DGP
Prof. Dr. Konstantin Mayer*, DGIIN
Prof. Dr. Erich Kilger*, DGAI
PD Dr. Ludwig Ney*, DGAI
Prof. Dr. Michael Pfeifer, DGIM
Dr. Simone Rosseau*, DGIIN
Reina Tholen*, ZVK
Dorothea Stanic*, Sepsishilfe e.V.
Prof. Dr. Roman Ullrich*, ÖGARI
Monika Veit*, BdO
Wolfgang Veit*, BdO
Prof. Dr. Norbert Weiler*, DGAI
Prof. Dr. Karl Werdan*, DGK
Methodological support Literature search and formal evaluation
Dr. Monika Nothacker, AWMF: project supervision
PD Dr. Helmuth Sitter*, AWMF: moderation 3rd consensus conference
Dr. Christiane Hofmann*, Leipzig University Library
Dr. Astrid Vieler*, Leipzig University Library
Dr. Annegret Franke*, Clinical Studies Center Leipzig University
Participating scientific societies Guideline supervision
Main issuing society:
(DGAI) German Society for Anesthesiology and Intensive Care Medicine
Participating societies and organizations:
(DIVI) German Interdisciplinary Association for Intensive Care and 
Emergency Medicine 
(SGI) Swiss Society for Intensive Care Medicine
(ÖGARI) Austrian Society for Anesthesiology, Resuscitation, and Intensive 
Care Medicine
(DGIM) German Society for Internal Medicine
(DGP) German Society for Pulmonology and Respiratory Medicine
(DGK) German Society for Cardiology and Cardiovascular Research
(DGIIN) German Society for Intensive Care Medicine and Emergency 
Medicine in Internal Medicine
(DGCH) German Surgical Society
(DGTHG) German Society for Thoracic, Cardiac, and Vascular Surgery
(DGNC) German Society for Neurosurgery
(DGN) German Neurological Society
(AWMF) Association of the Medical Scientific Societies in Germany
(DGNI) German Society for Neurointensive Care and
Emergency Medicine
(DGKJ) German Society for Pediatrics and AdolescentMedicine
(DGNPI) German Society for Neonatology and Pediatric Intensive Care
Medicine
(DGG) German Geriatric Society
(DGPalliativmedizin) German Society for Palliative Care
(DGHM) German Society for Hygiene and Microbiology
(DGF) German Society for Specialized Nursing and
Auxiliary Services
(ZVK) German Physiotherapy Association – Central
Association of Physiotherapists
(DGfK) German Society for Cardiotechnology
German Sepsis Aid
(BDO) German National Association of Organ Transplant Recipients
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on this evidence basis and categorized into 3 categories 
(Table 2). Clinical experience, patient preferences, and 
an assessment of mandatory resources were also taken 
into account. The strength of each recommendation is 
therefore not only bound to the previously assessed qual-
ity of the underlying evidence, but also on clinical judge-
ment. 
The members of the guideline group had to vote for or 
against the recommendations individually and in a sec-
ond stage as their role of mandate holders of 1 of the 21 
scientific societies. 
The following results section describes the main re-
sults of the guideline. In full, these results are comprehen-
sively described in the extended version of the guideline 
in German language [6]. Due to the close relation of our 
manuscript to the original full version of the guideline, 
parts of the guideline’s text may resemble the original 
wording without being marked as quotations.
Results
We present here not all, but key recommendations for 
choosing the ventilation mode and setting the parameters 
of mechanical ventilation, of which the guideline group 
expects suitable benefit, or – at least – the avoidance of 
harm for the patient if implemented in clinical practice. 
Furthermore, we present recommendations whose con-
tents deviate from current clinical practice or are still dis-
cussed controversially among clinicians. 
Table 2. Quality of evidence and strength of recommendation (GRADE Approach)
Quality of evidence
symbol assessment
++++ Quality of Evidence: high
Description
“[...] Further studies are very unlikely to change confidence of the guideline group 
in the estimate of effect [...]”
+++ Quality of Evidence: moderate
Description
“[...] Higher-quality studies may influence the confidence of the guideline group 
in the estimated effect or may change the estimate [...]”
++ Quality of Evidence: low
Description
“[...] Higher-quality studies are likely to influence the confidence of the guideline 
group in the estimated effect or to change the estimate [...]”
+ Quality of Evidence: very low
Description
“[...] There remains a high level of uncertainty about the estimated effect […]”
Expert consensus No relevant evidence available 
Strength of recommendation
assigned wording explanation
“[...] we recommend [...]”
“[...] we recommend, not to [...]”
Strong recommendation for/against
Description: “[…] strong confidence in the relation between desired and unde-
sired effects or strong predominance of benefits or risks […]”
“[...] we suggest [...]”
“[...] we suggest, not to [...]”
Weak recommendation for/against
Description: “[…] weak confidence in the relation between desired and undesired 
effects or weak predominance of benefits or risks […]”
“[…] we cannot give any recommendation […]” No recommendation
Description: “[…] no confidence in the relation between desired and undesired 
effects or no predominance of benefits or risks […]”
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Table 3. Modes of mechanical ventilation
Modes of mechanical ventilation
subgroup technical description abbreviation control/targeting
Modes of controlled ventilation
Volume-controlled ventilation VCV Set-point targeting:
application of volume-controlled ventilation
target: tidal volume
Pressure-controlled ventilation PCV Set-point targeting:
application of pressure-controlled ventilation
target: inspiratory pressure
Pressure-regulated volume control PRVC Set-point + adaptive: volume-controlled ventilation with
adaptive pressure changes
Modes of ventilation supporting spontaneous breathing
Tidal volume 
support
Assist-control ventilation A/C Set-point targeting:
application of (patient-triggered) volume-controlled
ventilation on the basis of set target variables





spontaneous breathing is assisted by a set amount of
pressure support
Variable pressure support noisy PSV Set-point targeting:




Volume-controlled synchronized intermittent manda-
tory ventilation
VC-SIMV Automatic adaptation of peak inspiratory pressure to ensure
a target tidal volume, time-controlled intermittent mandatory 
inspiration to ensure set minute volume
Pressure-controlled ventilation enabling spontaneous 
breathing in inspiration and expiration, for example, 
biphasic positive airway
pressure (BIPAP), airway pressure release ventilation 
(APRV); 




time-regulated, pressure-controlled ventilation enabling
spontaneous breathing during inspiration and expiration
Pressure-controlled synchronized intermittent manda-
tory ventilation
PC-SIMV Automatic adaptation of the tidal volume to ensure a target airway 
pressure, time-controlled intermittent mandatory inspiration to 
ensure set minute volume
Adaptive 
support
Adaptive support ventilation ASV Adaptive targeting or optimal targeting:
variable pressure-controlled or pressure-supported




Adaptive targeting or intelligent targeting: combination of ASV 
with additional treatment approaches
Neurally adjusted ventilatory assist NAVA Adaptive targeting or servo-targeting:
ventilation pressure proportional to respiratory effort, measured 
by the electrical activity of the diaphragm
SmartCare/PS SmartCare/
PS
Automatic adaptation of pressure support to keep the patient 
within a target comfort zone
Proportional assist ventilation und proportional assist 
ventilation plus
Synonym: proportional pressure support, PPS
PAV und 
PAV+
Automatic adaptation of the level of support and the performance
of the ventilator according to demand or respiratory effort
Hybrid modes of ventilation
For example, intermittent mandatory ventilation with pressure-support ventilation (IMV + PSV), intermittent mandatory ventilation with automatic tube 
compensation (IMV + ATC), biphasic positive airway pressure with pressure-support ventilation (BIPAP + PSV), biphasic positive airway pressure with 
automatic tube compensation (BIPAP + ATC), pressure-support ventilation with automatic tube compensation (PSV + ATC), and proportional assist 
ventilation with automatic tube compensation (PAV + ATC).
Special modes of ventilation
High-frequency oscillation ventilation HFOV High-frequency, constant-volume maintenance of a continually 
high airway pressure
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Can We Define Acute Respiratory Insufficiency?
Acute respiratory insufficiency is not defined uni-
formly. The central symptom of the conscious patient is 
shortness of breath, but impaired consciousness is also an 
important clinical sign. Hypoxemia, hypercapnia, and 
mixed forms can be distinguished by blood gas analysis, 
but general threshold values are missing. In clinical prac-
tice, patients are mechanically ventilated due to the clini-
cal judgment of the treatment team. 
Therefore, the guideline’s recommendations should 
always be applied whenever the treatment team assumes 
that mechanical ventilation or extracorporeal procedures 
have to be performed on a patient due to acute hypoxemic/
hypercapnic respiratory insufficiency.
For the clinical entity of ARDS, we applied the Berlin 
definition [10].
Choosing the Ventilation Mode
How Can Ventilation Modes Be Categorized?
The most important ventilation modes currently used 
in clinical routine have been categorized according to 
their capability of enabling and supporting spontaneous 
breathing efforts of the patient (Table 3). Thereby, the 
guideline group simplified the comprehensive taxonomic 
approach to mechanical ventilation developed by Chat-
burn et al. [11]. Despite the wide variety of ventilation 
modes available, only a limited number is regularly used 
in daily clinical practice. With controlled ventilation, the 
ventilator takes over the entire work of breathing (“con-
trolled ventilation modes”). If only part of the work of 
breathing is performed by the ventilator and the patient 
is not only allowed to breathe spontaneously but also is at 
least in part supported by the ventilator while breathing 
spontaneously this is called “assisted” ventilation. In 
many different modes, spontaneous breathing of the pa-
tient is possible and supported (“Ventilation modes that 
support spontaneous breathing”). A distinction is made 
between tidal volume-supporting ventilation modes 
(equal support of each breath), minute volume-support-
ing ventilation modes (intermittent mandatory breath 
strokes independent of individual inspiratory efforts), 
and adaptive ventilation modes (strength of support de-
pending on the inspiratory effort of the patient). Combi-
nations of these procedures we called hybrid ventilation 
modes. 
Should We Allow Spontaneous Breathing in 
Mechanically Ventilated Patients with Acute 
Respiratory Insufficiency?
When choosing the ventilation mode, it must be deter-
mined if the patient should be allowed to breath sponta-
neously while being mechanically ventilated. Need for 
deep sedation is associated with increased long-term 
mortality; therefore, a patient who is as less sedated as 
possible (and therefore usually having a higher amount of 
spontaneous breathing effort) is always a rational target 
for sedation [12]. Further, a number of smaller RCTs on 
patients with trauma-associated or mild-moderate ARDS 
showed beneficial effects (improvement of oxygenation, 
lower level of sedation needed, etc.) of early spontaneous 
breathing assisted by different ventilation modes, but 
there is still no sufficient data demonstrating positive ef-
fects on ICU- or in-hospital mortality [13–16]. Thus, for 
all mechanically ventilated patients with acute respiratory 
insufficiency (except severe ARDS), we suggest using an 
assisted ventilation mode to enable spontaneous breath-
ing early (< 48 h after intubation) (QE: +, StoRe: weak). In 
patients in whom spontaneous breathing activity has to 
be avoided due to the underlying medical condition (e.g., 
increased intracranial pressure), the benefit and risk of 
assisted ventilation have to be assessed individually.
In patients with severe ARDS, a significant reduction 
in 28-day mortality was achieved by applying neuromus-
cular blockade to prevent spontaneous breathing (cis-
atracurium 23.7% [95% CI 18.1–30.5] vs. control 33.3% 
[95% CI 26.5–40.9]) [17]. Due to the limited methodolog-
ical quality of the trial (insufficient statistical power for 
primary outcome, unusual low PEEP levels, usage of cis-
atracurium in control group, etc.) and the risk of too deep 
sedation for patients with severe ARDS, we cannot cur-
rently neither recommend for nor against allowing spon-
taneous breathing within the first 48 h of mechanical ven-
tilation (no recommendation). The ROSE trial, published 
after completion of the guideline, showed no effects of 
early neuromuscular blockade in patients with ARDS, but 
gives no further information about the question of ben-
efits and risks of spontaneous breathing in severe ARDS 
[18].
Should We Prefer Pressure – or Volume-Controlled 
Ventilation if Controlled Ventilation Is Necessary?
Ventilation modes for controlled ventilation are gen-
erally divided into pressure-controlled ventilation (PCV) 
and volume-controlled ventilation (VCV). Roughly, for 
VCV, a fix tidal volume is applied regardless of the gener-
ated peak inspiratory pressure, while for PCV, a fix peak 
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inspiratory pressure is applied regardless of the generated 
tidal volume. In the foretimes of intensive care, it was hy-
pothesized that VCV might generate higher inspiratory 
pressure and therefore more ventilator-induced lung in-
jury. At least in Europe, PCV was widely accepted as the 
appropriate controlled ventilation mode for patients with 
acute respiratory insufficiency.
In a recent major meta-analysis, pressure-controlled 
ventilation did not reduce hospital mortality (nor 28 days 
mortality) compared to volume-controlled ventilation 
[19]. ICU mortality in patients with PCV was slightly re-
duced in comparison to VCV (relative risk 0.84, 95% CI 
0.71–0.99, 1,062 patients, 2 studies). Neither incidence of 
barotrauma (relative risk 1.24, 95% CI 0.87–1.77, 1,062 
patients, 2 studies) nor duration of invasive ventilation 
was positively affected by PCV. Data on incidence of or-
gan failure and duration of ICU and hospital stay were 
rejected by the authors of the meta-analysis since they 
were not interpretable due to poor quality. The overall 
quality of evidence for the central critical outcome pa-
rameter “mortality” was considered to be moderate due 
to a lack of precision. The quality of data on barotrauma 
was assessed as low due to lack of precision and clinical 
heterogeneity of the methodology (use of recruitment 
maneuvers only in the treatment group PCV). Based on 
this meta-analysis including all major RCTs, patients 
with acute respiratory insufficiency can be ventilated us-
ing either PCV or VCV. We cannot give any recommen-
dations for or against either of the 2 controlled ventilation 
modes (QE: +++, no recommendation).
Is There Any Benefit Using Tidal-Volume-Supporting 
Ventilation Modes?
Apart from 2 individual studies [20, 21] showing some 
improvement in gas exchange under pressure-support 
ventilation compared to controlled ventilation, only 
pathophysiological considerations (e.g., avoiding inacti-
vation atrophy of the respiratory muscles) argue for the 
use of PSV instead of controlled ventilation. Hence, de-
spite the widespread use of tidal volume supporting ven-
tilation modes, we cannot give evidence-based recom-
mendations for or against it as the ventilation mode in 
mechanically ventilated patients with acute respiratory in-
sufficiency due to a lack of clinical data on benefit and risk.
Nevertheless, refer to the following paragraph on min-
ute-volume-supporting ventilation modes in accordance 
with the initial weak recommendation in favor of the ear-
ly use of an assisted ventilation mode in patients with 
acute respiratory failure to enable early spontaneous 
breathing (excepting severe ARDS).
Is There Any Advantage for Our Patients Using 
Minute-Volume-Assisted Ventilation Modes?
While one of the first widely used ventilation modes 
for minute volume-assisted ventilation was SIMV (syn-
chronized intermittent mandatory ventilation), which is 
still widely used, there is now a large number of related 
modern ventilation modes (e.g., airway pressure release 
ventilation, biphasic positive airway pressure [BIPAP], 
BiVent, etc.) switching between 2 different pressure levels 
using demand valves to enable spontaneous breathing at 
each phase of the respiratory cycle. We generally use the 
term airway pressure release ventilation/BIPAP for all 
variants of pressure-controlled ventilation with the pos-
sibility of spontaneous breathing in the inspiration and 
expiration phases.
Larger randomized controlled trials on minute vol-
ume-assisted ventilation modes enabling spontaneous 
breathing in patients with ARDS are lacking. Hence, rec-
ommendations are based on small randomized [15] and 
observational studies in heterogeneous patient cohorts 
[22]. The positive effects of minute volume-assisted ven-
tilation modes on oxygenation and systemic blood flow 
have been well documented in numerous experimental 
and some small clinical studies [23, 24] and suggested that 
early spontaneous breathing might be allowed. In addi-
tion, there are some benefits, which might be induced by 
allowing spontaneous breathing activities: A reduced 
need for sedation with fewer hemodynamic side effects, 
supposedly less delirious states and cognitive dysfunction 
and more alert, spontaneously breathing patients that 
might be mobilized earlier to counteract muscular inac-
tivity atrophy. Keeping in mind the low quality of the un-
derlying evidence due to the lack of large RCTs and the 
methodological heterogeneity of the studies, the follow-
ing recommendation was given: Weighing the potential 
clinical benefits and the lack of evidence for relevant 
harm, we suggest to consider the use of pressure-con-
trolled ventilation with the possibility of spontaneous 
breathing in the inspiratory and expiratory phases in pa-
tients without severe ARDS. Further, the individual pa-
tients particular medical conditions (e.g., increased ICP) 
should be considered as contraindication for spontane-
ous breathing (QoE: ++, StoRe: weak).
Should We Use Adaptive Ventilation Modes in 
Patients with Acute Respiratory Insufficiency?
The basic principle of these modes is the intra- and in-
terindividual adaptation of ventilatory support to the ac-
tual needs of the individual patient. The increasing degree 
of automation enables the processing of protocols by the 
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ventilator, aiming on the de-escalation of the ventilation 
or weaning of the patient. For patients with acute respira-
tory insufficiency, there is currently no available data 
demonstrating a clear survival benefit from the use of 
adaptive ventilation modes. In a number of studies inves-
tigating different modes (Adaptive Support Ventilation, 
Neurally Adjusted Ventilator Assist, SmartCare/PS, Pro-
portional Assist Ventilation etc.), the main proven clini-
cal benefits have been observed in the improved synchro-
nization of patient and ventilator (e.g., [25, 26]). This cur-
rently might be of clinical importance in hypercapnic 
patients, in whom a significant improved synchroniza-
tion of patient and ventilator can be achieved. The main 
disadvantage of adaptive ventilation is that these algo-
rithms do not ensure the application of low tidal volumes 
and can result in tidal volumes that significantly exceed 6 
mL/kg. Therefore, we cannot give any recommendation 
on the use of adaptive ventilation modes for ARDS pa-
tients. For patients suffering primary hypercapnic respi-
ratory insufficiency, we suggest to consider using adap-
tive ventilation modes to improve the interaction be-
tween patient and ventilator and to increase patient 
comfort while closely monitoring for avoidable intensity 
of ventilation (QeE: +, StoRe: weak).
Should We Use Hybrid Ventilation Modes in 
Mechanically Ventilated Patients?
Hybrid ventilation modes combine assisted ventilation 
that supports tidal volume with assisted ventilation that 
supports minute volume in many different combinations 
and under many different names (IMV + PSV, IMV + ATC, 
Intermittent Mandatory Release Ventilation, BIPAP + 
PSV, BIPAP + ATC, PSV + ATC, and Proportional Assist 
Ventilation + ATC). The aim of hybrid ventilation methods 
is to combine the beneficial characteristics of the different 
ventilation modes in 1 single mode for the patient.
Until now for hybrid ventilation modes, their advantage 
with regard to clinically relevant outcome parameters for 
patients with acute respiratory insufficiency has not been 
investigated by high-quality controlled trials. Due to the 
lack of comparative clinical data, the guideline group is 
currently unable to make an evidence-based recommenda-
tion for or against the use of hybrid ventilation modes.
Should We Use HFOV to Treat Patients Suffering from 
Severe ARDS?
HFOV generates a continuous high airway pressure 
(PAW) and thus elevated transpulmonary pressure (TPP) 
in an open ventilation system using high gas flow, which 
theoretically should lead to an improved alveolar recruit-
ment. High-frequency vibrations of the gas flow, induced 
by the ventilator, ensure gas exchange without signifi-
cantly increasing the PAW or PTP and, probably, the 
consecutive decreased ventilator-induced lung injury.
After earlier trials showed improvements in oxygen-
ation in patients with severe ARDS treated with HFOV 
[27], the newest 2 large RCTs showed no differences in 
30-day survival [28] , or an increased hospital mortality 
(HFOV 47% vs. control 35%) [29] using HFOV. As ex-
pected, subsequent meta-analyses showed no reduction 
in 30-day or in-hospital mortality and in some cases less 
ventilator free days and an increased length of intensive 
care stay for the use of HFOV in predominantly adult 
(> 18 years) patients with moderate and severe ARDS 
(PaO2/FIO2 < 200) [30, 31]. 
To avoid harm to the patients, we recommend not to 
use HFOV in patients with ARDS (QoE: ++++, StoRe: 
strong).
How to Set the Ventilator
Which PEEP-Level Should Be Chosen for Patients 
with ARDS?
PEEP is thought to counteract a reduction in function-
al residual capacity by keeping alveoli open and therefore 
avoiding formation of atelectases. PEEP application is in-
tended to improve oxygenation. By increasing intratho-
racic pressure und diminishing venous blood flow into 
the thorax, its application goes not without risks for some 
patients (i.e., hyperinflation of localized lung areas, drop-
ping cardiac output, or increasing intracerebral pres-
sure).
Hence, the PEEP-level has to be adjusted according to 
patient’s respiratory condition while considering poten-
tial side effects on other organs. 
For patients with ARDS, different methods of setting 
PEEP have been suggested, including imaging technolo-
gies (e.g., computed tomography [32] or bedside electri-
cal impedance tomography [EIT] [33]), bedside measure-
ments of respiratory pressure-volume-curves, or serial 
blood gas analysis. In contrast, setting of PEEP according 
to ventilator protocol cards of the ARDS network [34] is 
probably the easiest way in clinical practice, but it leaves 
completely aside the individual respiratory condition of 
the patient treated. 
The original ARDS network ventilator protocol cards 
presented 2 PEEP tables (lower PEEP/higher FiO2 and 
higher PEEP/lower FiO2), in which different PEEP levels 
are proposed to be applied depending on the FiO2. The 
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high PEEP/lower FiO2 table presented here was used in 
the ALVEOLI study [35] before protocol adjustment to 
even higher PEEP values.
The following aspects speak in favor of applying high-
er PEEP levels: 
 − proven reduction in ARDS mortality using higher 
PEEP levels combined with low tidal volumes com-
pared to traditional ventilation demonstrated in sev-
eral RCTs and subsequent meta-analyses [36, 37].
 − observed reduction in ICU and hospital mortality of 
patients with severe ARDS using higher PEEP levels 
compared to lower PEEP levels while maintaining pro-
tective tidal volumes in both groups [38].
 − no significant negative effects (no differences in signs 
of barotrauma) [36–38].
Weighing the evidence for benefits and risks the guide-
line group strongly recommends the use of a higher PEEP 
level for all ARDS patients (QoE:++++, StoRe: strong).
Taking into account its simplicity and easy implementa-
tion, we suggest setting PEEP levels according to the 
ARDS network ventilator protocol cards (QoE: ++, StoRe: 
weak). 
Which Level of PEEP Should Be Used in Mechanically 
Ventilated Patients without ARDS?
For mechanically ventilated patients without ARDS, 
there is no evidence of positive effects on survival, ICU 
length of stay, or ventilator free days, if these patients 
were ventilated with a higher PEEP, but ventilation with 
a PEEP of ≥5 cm H2O showed better oxygenation and 
lung compliance and no relevant risks if compared to 
ZEEP [39]. The guideline group recommends the general 
use a PEEP of ≥5 cm H2O in mechanically ventilated pa-
tients without respiratory failure in intensive care (QoE: 
+, StoRe: strong).
Which Level of PEEP Should Be Used in Patients 
Suffering Acute Hypercapnic Respiratory 
Insufficiency?
In chronic obstructive pulmonary disease, progressive 
airway obstruction causes expiratory trapped air due to 
the inability to exhale completely. The resulting intrinsic 
PEEP adds to the inspiratory resistance and increases the 
inspiratory respiratory work of the patient. For mechani-
cally ventilated, spontaneously breathing patients the in-
creased inspiratory workload translates into an increased 
inspiratory work on the ventilator. Therefore, in these pa-
tients, the application of the correct level of external PEEP 
can reduce the increased inspiratory trigger work caused 
by intrinsic PEEP and prevent respiratory collapse during 
forced expiration. In contrast, if the externally applied 
PEEP is too high, it will become an expiration obstacle 
and increase the work of breathing additionally.
There are no randomized controlled trials available in-
vestigating the effect of externally applied PEEP in me-
chanically ventilated patients with acute hypercapnic re-
spiratory insufficiency in terms of survival and quality of 
life as well as ventilator-free days nor ICU-length of stay. 
The 2016 guideline of the British Thoracic Society on hy-
percapnic respiratory failure, based on evidence of low 
quality (case–control studies, physiological outcome pa-
rameters), concludes that an externally applied PEEP 
should not exceed 12 cm H2O in patients with hypercap-
nic respiratory failure [40].
A Brazilian clinical experts guideline from 2014 sug-
gests the use of an external PEEP of 3–5 cm H2O for inva-
sive ventilation of patients with acute bronchial asthma, 
whereas in patients with exacerbated chronic obstructive 
pulmonary disease, the external PEEP can be adjusted de-
pending on the change in the exhaled tidal volume: the 
externally applied PEEP can be increased until the PEEP-
induced increase in the exhaled tidal volume turns into a 
decrease. For assisted spontaneous breathing, the Brazil-
ian guideline recommends an external PEEP at a level of 
approximately 85% of the intrinsic PEEP, but the diffi-
culty of measuring the intrinsic PEEP while breathing 
spontaneously is not further discussed. Without any data 
from prospective controlled clinical trials, this statement 
has only a level of an expert recommendation.
Due to the lack of clinical data on critical outcome pa-
rameters, our recommendation to adjust the PEEP in 
acute hypercapnic respiratory insufficiency is based on 
pathophysiological considerations of respiratory me-
chanics (breathing work, triggering, etc.) and follows the 
expert recommendation of the Brazilian guideline.
Thus, in mechanically ventilated patients with acute 
hypercapnic respiratory insufficiency, we suggest using 
extrinsic PEEP up to 85% of intrinsic PEEP (QoE: – [ex-
pert recommendation], StoRe: weak).
Can We Define a Goal for Setting FiO2?
There are neither high-quality trials showing evidence 
of toxicity of high oxygen concentrations in adult patients 
with lung failure nor any controlled studies showing a 
causal relationship between FiO2 and mortality or other 
relevant outcome data. In an observational study, hyper-
oxia was associated with increased mortality [41]. Fur-
ther, in 2 smaller RCTs, no increased mortality or organ 
failure rate was observed in mechanically ventilated pa-
tients with restrictive FiO2 settings [42, 43]. 
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Due to the low quality of evidence, we suggest as an ex-
pert consensus to adjust the FiO2 during mechanical ven-
tilation in order to achieve a SaO2 of 90–94% or a PaO2 
of 60–80 mm Hg (8.0–11.7 kPa). The guideline group rec-
ommends SaO2 of 90% as the lower limit of SaO2, since 
the actual measured saturation was higher than 90% in 
many studies, even though a range of SaO2 of 88–92% was 
stated in the study protocol in individual cases.
The guideline group primarily recommends the use of 
arterial saturation or arterial partial pressure due to po-
tential difficulties in peripheral measurement with a pulse 
oximeter. If the measured peripheral saturation matches 
the arterial saturation, it can also be used.
Should the Tidal Volume Be Limited in Mechanically 
Ventilated Patients with ARDS?
During positive pressure invasive ventilation, the lung 
inflation is associated with a cyclically increased intrapul-
monary pressure and thereby cyclically increased trans-
pulmonary pressure (TPP). The cyclic increase in TPP 
causes a certain amount of distension and elongation of 
the lung parenchyma. Levels of lung distension exceeding 
the elastic capacity of the lung causes direct and indirect 
pulmonary damage (ventilator-associated lung injury) 
and are suspected to result in progression of multiple or-
gan failure in ARDS patients [44, 45]. 
Meta-analyses [37, 46] comparing RCTs with low VT or 
low end-inspiratory pressures (PEI) < 30 cm H2O (resulting 
in VT < 7 mL/kg standard body weight [SBW]) versus ob-
served VT 10–15 mL/kg SBW with and without change of 
PEEP showed reductions in hospital mortality in patients 
with ARDS, which was even more prominent if low VT and 
higher PEEP-levels were combined. The quality of evidence 
is moderate due to heterogeneity of the study data.
Considering the documented benefits and no further 
evidence of harm, the guideline group recommends me-
chanical ventilation with a tidal volume VT ≤6 mL/kg 
SBW for patients with ARDS (QoE: +++, StoRe: strong).
Mechanical ventilation using low tidal-volume strat-
egy may lead to significant hypercapnia in certain pa-
tients. If hypercapnia has to be avoided in individual 
treatment settings (e.g., intracranial hypertension, severe 
pulmonary hypertension, acute right heart failure), a 
thorough weighing of benefits and risks for the individu-
al patient is necessary.
Should the Tidal Volume Be Limited in Mechanically 
Ventilated Patients without ARDS?
The adverse effects of mechanical ventilation on lung 
parenchyma and other organs are not limited to pa-
tients with ARDS, since the same pathophysiologi- 
cal phenomena (cyclic hyperinflation) can occur in a 
healthy lung.
A meta-analysis from 15 trials demonstrated a re-
duced length of mechanical ventilation and lower risk for 
postoperative pulmonary complication rates using 
smaller VTs (6–8 mL/kg SBW) in patients without ARDS 
receiving mechanical ventilation during surgery or in 
ICU [47]. 
Therefore, the guideline group recommends invasive 
ventilation of patients without ARDS with a VT of 6–8 
mL/kg standard KG (QoE: +++; StoRe: strong). 
Exceptions from this recommendation are in line with 
those discussed in the previous section.
Is There Any Upper Limit for Peak Inspiratory 
Pressure?
The terms respiratory peak pressure, PEI, and peak in-
spiratory pressure are used to describe types of the highest 
inspiratory pressures depending on the actual mode of 
mechanical ventilation. Volume-controlled ventilation 
with constant inspiratory flow results in a peak airway 
pressure (Ppeak) higher and earlier in the inspiratory cy-
cle than the PEI. PEI is measured at the end of the inspi-
ratory cycle. In pressure-controlled modes, an inspiratory 
airway pressure (Pinsp) is usually given, which is roughly 
equivalent to the PEI. The driving pressure (ΔP) is the 
difference between PEI and PEEP and thus the driving 
force for lung inflation during inspiration.
Application of high inspiratory pressures during me-
chanical ventilation might induce hyperinflation of the 
lung parenchyma (barotrauma). Thus, limitation of in-
spiratory respiratory pressure to prevent barotrauma is 
part of lung-protective ventilation strategies. However, 
Pinsp is only one of several parameters, which can be 
adapted to prevent barotrauma. Depending on the focus 
of the ventilation strategy, end-inspiratory or peak inspi-
ratory pressures may be just the result of the PEEP-levels 
or tidal volumes applied to a respiratory system with a 
reduced compliance.
In a high-quality Cochrane meta-analysis, the effect of 
lung-protective ventilation in patients with ARDS was 
analyzed. An absolute reduction of mortality about 10% 
was observed only in the combined data of 3 studies (n = 
1,009 patients) in which the inspiratory pressure of the 
control group was above 31 cm H2O [46]. Neither data 
from the individual RCTs nor from combined meta-anal-
ysis showed if the reduction of peak inspiratory pressure 
or the limitation of tidal volume was primary related to 
the observed mortality reduction.
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According to the evidence, we recommend limiting 
end-inspiratory airway pressure in patients with ARDS to 
≤30 cm H2O (QoE: +++, StoRe: strong). 
For other groups of patients with acute respiratory in-
sufficiency no prospective multi-center RCTs exist. Since 
data on patients with ARDS showed no evidence of harm, 
the guideline group suggests limiting endinspiratory air-
way pressure in patients with acute respiratory insuffi-
ciency to ≤30 cm H2O (QoE: +++, StoRe: weak). 
Should We Aim on a Certain Driving Pressure Limit?
The correlation of driving pressure (ΔP) and mortality 
was investigated in a retrospective analysis of data from 
several prospective randomized controlled studies [48]. 
Ventilatory parameters of a total of 3,562 mechanically 
ventilated patients were analyzed retrospectively and 
showed that an increased driving pressure in ARDS pa-
tients was associated with an increased mortality. This 
correlation was independent of different PEEP levels and 
observable at different PEI levels. A large-scale observa-
tional study in ARDS patients and an individual patient 
data analysis of patients with ARDS treated with ECMO 
reported similar correlations of driving pressure and hos-
pital mortality [49, 50]. 
Since underlying data are either observational or de-
rived retrospectively, the evidence we ground our recom-
mendation on is weak: We suggest to limit the driving 
pressure level 15 cm H2O if possible (QoE: +, StoRe: weak).
Exceptions: In obese patients or patients with in-
creased intra-abdominal pressure, a higher PEI may be 
necessary. There are no prospective randomized studies 
that prove the safety of such an approach.
How Should the Ratio of Inspiration to Expiration 
Time Be Adjusted in Acute Hypoxemic Respiratory 
Failure?
Under the conditions of controlled ventilation, the in-
spiration (I) and expiration (E) times and the I:E ratio are 
specified by the ventilator settings. The setting of I:E ratio 
depends on the underlying cause of respiratory failure. In 
acute hypoxemic respiratory failure with reduced com-
pliance, collapsed lung areas and reduced functional re-
sidual capacity, prolonging inspiration time while short-
ening expiration time might increase intrinsic PEEP and 
may contribute to an improvement in alveolar recruit-
ment and oxygenation [51, 52].
Controlled trials on inversed ratio ventilation (I:E > 1) 
mainly investigated direct effects on surrogate parame-
ters (e.g., pulmonary gas exchange and respiratory me-
chanics). Without stratification of severity of ARDS and 
by not using lung-protective ventilation no solid assess-
ment of benefits and risks is possible from data provided 
by these trials. Those older studies make it difficult to as-
sess a possible treatment benefit.
However, measuring intrinsic PEEP (induced by I:E > 
1) is difficult and imprecise; therefore, application of ex-
ternal PEEP with an I:E ≤1 will result in better-defined, 
constant, and controllable pressure levels. Furthermore, 
negative effects of inconstant intrinsic PEEP on barotrau-
ma and VILI are unknown.
Due to lack of sound evidence of effects of different I:E, 
as an expert consensus, we suggest mechanical ventila-
tion using a prolonged I:E ratio (1: 1.5 to 1: 1) for patients 
with acute hypoxemic respiratory failure (QoE: –, StoRe: 
weak); we give a weak recommendation against the use of 
inverse ventilation (I:E > 1) (QoE: ++, StoRe: weak).
How Should the Relation of Inspiration to Expiration 
Time Be Adjusted in Acute Hypercapnic Respiratory 
Insufficiency?
In acute hypercapnic respiratory failure, limitations or 
truncation of expiratory flow causes pulmonary hyperin-
flation and intrinsic PEEP, which can be prevented or at 
least ameliorated by extending expiratory flow time [53]. 
In contrast to this neat pathophysiological concept, we 
did not find any high-quality prospective clinical study 
investigating the influence of different I:E ratios in pa-
tients with acute hypercapnic respiratory insufficiency. 
The members of the guideline group could only give rec-
ommendations on an expert consensus level based on 
theoretical considerations and clinical experiences.
Based on these, we assume that mechanically venti-
lated patients with acute hypercapnic respiratory failure 
might benefit from a prolonged expiratory time. 
When adjusting the inspiratory to expiratory time ra-
tio (I:E), we recommend taking into account the charac-
teristics of the pressure and flow curves displayed by the 
ventilator (QoE: –, StoRe: strong).
We suggest to adjust the I:E ratio in mechanically ven-
tilated patients with hypercapnic respiratory insufficien-
cy with signs of expiratory flow limitation to achieve the 
longest possible expiratory phase while simultaneously 
maintaining a sufficient tidal and respiratory minute vol-
ume (QoE: –, StoRe: weak).
Which Respiratory Rate Is to Be Set in Mechanically 
Ventilated Patients?
There are no RCTs available answering the question of 
the optimal ventilation frequency in ARDS. The ARDS-
Network trial protocol is frequently cited, although the 
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trial does not provide information to evaluate optimal 
frequency or possible effects on clinically relevant out-
come or surrogate parameters [54]. In the large observa-
tional LUNG-SAFE trial with 2377 ARDS patients – be-
sides other factors – low-frequency ventilation was asso-
ciated with increased survival [50]. In sum, without 
existing sound data, we cannot give any recommendation 
on the setting of respiratory rate in mechanically venti-
lated patients with acute respiratory insufficiency.
Which Monitoring Should Be Used Treating Patients 
on Mechanical Ventilation? 
Patients who require invasive ventilation due to acute 
respiratory insufficiency are considered at high-risk for 
life-threatening state of illness. Monitoring ventilatory 
settings and resulting parameters as well as oxygenation 
and CO2 elimination are considered obligatory. In addi-
tion, the extrapulmonary effects of mechanical ventila-
tion should be monitored additionally. Naturally, the 
same principles apply for patients treated with ECMO, 
who are even more complex and must be monitored care-
fully, extensively, and thoroughly.
On expert consensus level, we recommend as minimal 
monitoring for patients with acute respiratory failure 
continuous pulse oximetry, continuous ECG, and con-
tinuous blood pressure measurements (QoE: –, StoRe: 
strong).
There are no sound data on the benefit/risk ratio of a 
definite frequency of arterial blood gas analyses in pa-
tients with acute respiratory insufficiency. While repeti-
tive arterial blood gas analyses provide robust data on ox-
ygenation and CO2 – elimination, the cumulative blood 
loss, and the prolonged arterial vascular access can cause 
relevant harm to the patient.
We recommend regularly repeated monitoring of ar-
terial blood gases in mechanically ventilated patients 
(QoE: –, StoRe: strong). 
The term “regular” cannot be defined here more pre-
cisely on scientific bases. The frequency of regular arte-
rial blood gas analyses should in any case be individually 
adapted to the clinical situation and potential therapeutic 
decision based on the analysis.
Furthermore, likewise without reasonable data, the 
guideline group comes to the conclusion that in venti-
lated patients with acute respiratory insufficiency it is es-
sential to monitor the ventilation parameters for reasons 
of patient safety.
For mechanically ventilated patients with acute respi-
ratory insufficiency, we recommend continuous moni-
toring of the ventilatory parameters (airway pressures, 
tidal volume, I:E ratio, respiratory rate, flow time curves) 
(QoE: –, StoRe: strong).
When and How Should We Use Capnometry and 
Capnography in Mechanically Ventilated Patients?
In capnometry, the carbon dioxide partial pressure in 
the breathing gas is determined by infrared spectrometry 
using the main or bypass flow method. The additional 
graphic representation is called capnography. The accu-
racy of the measurement is 5%. In patients with acute re-
spiratory insufficiency and ARDS as well as patients with 
pulmonary embolism, however, it should be noted that 
increased ventilation perfusion mismatch might result in 
a large difference between the end-expiratory and arte-
rial CO2 partial pressure.
Several clinical practice guidelines recommend cap-
nography/capnometry to confirm the endotracheal tube 
position after intubation and during mechanical ventila-
tion for reasons of patient safety. Our guideline group 
followed those recommendations:
We recommend to apply capnometry or capnography 
during intubation to verify endotracheal tube position 
(QoE: ++, StoRe: strong).
We suggest using capnometry or capnography to 
monitor mechanical ventilation (QoE: ++, StoRe: weak).
A monitoring procedure per se cannot improve the 
outcome of patients, a treatment algorithms based on the 
results of a monitoring procedure might be able to im-
prove outcome.
Should We Use a Pulmonary-Artery Catheter or 
Transpulmonary Thermodilution in Patients with 
Acute Respiratory Insufficiency?
Several studies on the use of the pulmonary artery 
catheter in ARDS patients did not show any beneficial ef-
fects [55–57] on clinically relevant outcome parameters. 
The International Guidelines for the Treatment of Severe 
Sepsis and Septic Shock strongly discourage routine use 
of the pulmonary arterial catheter in patients with sepsis-
induced ARDS. The use should be limited to selected pa-
tients and it should be taken strict care to ensure correct 
interpretation of the measured items [58].
A prospective randomized trial investigating the ben-
efit of volume and catecholamine therapy guided by 
transpulmonary thermodilution in patients with septic 
shock and/or ARDS was discontinued early for futility 
[59].
In the absence of evidence for benefits of the general 
use of pulmonary artery catheter or transpulmonary ther-
modilution in patients with acute respiratory insufficien-
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cy and in consideration of potential harm of the invasive 
procedure, the guideline group agrees with the recom-
mendation of the SSC Guideline Committees [58]. In the 
subgroup of patients with right ventricular dysfunction 
or acute pulmonary or coronary artery disease, therapy 
might be accompanied by the use of a pulmonary arterial 
catheter or echocardiography.
We recommend against the routine use of pulmonary 
artery catheter in patients with acute respiratory insuffi-
ciency (QoE: +++, StoRe: strong).
We suggest that in patients with acute respiratory in-
sufficiency and signs of right ventricular dysfunction the 
use of a pulmonary arterial catheter or echocardiography 
should be considered to control therapy (QoE: –, StoRe: 
weak).
Are There Any Other Beneficial Methods of 
Monitoring for Mechanically Ventilated Patients?
A large number of other monitoring methods exist 
providing additional information for the treatment pa-
tients with acute respiratory insufficiency. A systematic 
literature search on the different types of monitoring fo-
cusing on outcome parameters relevant for this guideline 
was not performed since we expected only a very small 
amount of clinically relevant literature. 
In general, no recommendations for routine applica-
tion can be given for any method, since there are still in-
sufficient outcome data to rely on.
Transpulmonary thermodilution enables the determi-
nation of intrapulmonary blood volume and extravascu-
lar lung water. The pulmonary vascular permeability in-
dex can also be calculated. Extravascular lung water cor-
relates with the extent of pulmonary edema and therefore 
might be possible to discriminate patients with ARDS or 
cardiac pulmonary edema from patients with atelectasis 
or pleural effusion [60]. 
EIT is an imaging technique based on repetitive mea-
surement of the electrical conductivity of biological tissues. 
Electrodes placed around the chest can detect and visualize 
intrathoracic impedance changes during the respiratory 
cycle, which strongly correlate with changes in regional 
pulmonary ventilation. The effect of mechanical ventila-
tion, recruitment maneuvers, and changes in PEEP and tid-
al volume as well as body positioning on the distribution of 
pulmonary ventilation in patients with acute respiratory 
insufficiency was demonstrated by EIT [61]. However, uni-
formly defined standards of measurement as well as data 
analysis and interpretation are necessary in order to further 
investigate the implication of EIT in the treatment of pa-
tients with acute respiratory insufficiency [62, 63].
Conclusion
This clinical practice guideline, developed by repre-
sentatives of all relevant different disciplines and profes-
sions involved in the treatment of mechanically venti-
lated patients with acute respiratory insufficiency and by 
patient representatives, is intended to provide a source 
of information and an aid for decision-making for the 
main therapeutic questions in mechanical ventilation in 
patients with acute respiratory insufficiency. Following 
the GRADE approach of systematic literature search and 
quality assessment of the data, always considering needs 
and interests of the patients, the guideline group weighed 
up benefits and risks to finally give recommendations for 
or against many different therapeutic strategies.
This review focused on the core of mechanical ventila-
tion therapy: choosing ventilation mode and setting pa-
rameters of mechanical ventilation.
After having indicated the need for mechanical venti-
lation for a patient, the central initial question to answer 
before choosing a ventilation mode is whether the pa-
tient should be allowed to breathe spontaneously or not. 
For most patients with acute respiratory insufficiency, 
breathing spontaneously in lightly sedated state as soon 
as possible after initiation of mechanical ventilation is 
crucial step to successful weaning, but some exceptions 
have to be considered carefully. Until now, no single 
mode of mechanical ventilation was shown to be supe-
rior to others, but there is growing evidence that modes 
enabling spontaneous ventilation during the complete 
respiratory cycle are beneficial. Two central issues on 
mechanical ventilation in patients with ARDS should be 
emphasized here:
First, the concept of neuromuscular blockade and con-
trolled ventilation during the early severe ARDS is under 
an ongoing scientific debate and high-quality multicenter 
trials to confirm or disprove the data of the initial land-
mark study were awaited after the publication of the 
guideline. Recently, the ROSE trial was published, which 
showed no benefits for early neuromuscular blockade in 
ARDS, but from the data published in the ROSE trial it is 
not clear to which degree patients in the group without 
neuromuscular blockade were breathing spontaneously 
[18].
Second, HFOV is the only mode of mechanical venti-
lation for which the evidence published showed possible 
harm without detectable benefit; therefore, a strong rec-
ommendation against the use was made. 
Quality of evidence for different settings on the venti-
lator was much higher. Hence, the guideline group gave 
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strong recommendations for lung-protective ventilator 
setting of patient-adapted individual higher PEEP, a tidal 
volume limited to 6–8 mL/kg, and an upper airway pres-
sure level kept below 30 cm H2O for most of the patients 
with acute respiratory insufficiency. All 3 parameters 
were in general automatically recorded by modern pa-
tient data management systems. Adaption of the 3 recom-
mendations in clinical practice can therefore be used as 
an indicator of quality of care.
Finally, the guideline group defined important re-
search questions in order to close the gaps of scientific 
knowledge on mechanical ventilation for the benefit of 
our future patients. From the guideline group’s perspec-
tive, strong confirmative data are needed on the impact 
of allowing or even augmenting early spontaneous breath-
ing in mechanically ventilated patients, especially in pa-
tients with ARDS. Furthermore, it has to be clarified, 
whether certain adaptive ventilation modes, that is, en-
abling automatically ventilator support to be individual-
ized to the patient’s actual needs, are beneficial. 
The next review of the guideline is scheduled in 2022. 
The authors of this review are deeply grateful to all mem-
bers of the guideline group, who, through their voluntary 
work over a period of 4 years, made it possible to finally 
successfully complete this guideline project.
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